115 related articles for article (PubMed ID: 31471573)
1. Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
Herr MM; Torka P; Zhang Y; Wallace PK; Tario JD; Repasky EA; Chen GL; Ho CM; Balderman SR; Ross M; Paiva B; Hernandez-Ilizaliturri FJ; McCarthy PL; Hahn T
Bone Marrow Transplant; 2020 Jan; 55(1):272. PubMed ID: 31471573
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
[TBL] [Abstract][Full Text] [Related]
3. Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
Yang L; Tan Y; Shi J; Zhao Y; Zhu Y; Hu Y; Pan W; Ye Y; He J; Zheng W; Sun J; Cai Z; Huang H; Luo Y
Bone Marrow Transplant; 2020 Oct; 55(10):2056. PubMed ID: 32541688
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: Lithospheric mantle buoyancy: the role of tectonic convergence and mantle composition.
Boonma K; Kumar A; Garcia-Castellanos D; Jiménez-Munt I; Fernández M
Sci Rep; 2020 Jan; 10(1):761. PubMed ID: 31937910
[TBL] [Abstract][Full Text] [Related]
5. Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.
Farooq U; Laport GG
Leuk Lymphoma; 2015 Jul; 56(7):1930-7. PubMed ID: 25315072
[TBL] [Abstract][Full Text] [Related]
6. Autologous hematopoietic stem cell transplantation as first-line consolidation therapy can improve the prognosis of diffuse large B-cell lymphoma with high expression of MYC protein.
Hu K; Gao JJ; Li QH; Tian L; Wan W; Zhao W; Wang JJ; Fu L
Kaohsiung J Med Sci; 2019 Jul; 35(7):425-431. PubMed ID: 31050117
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cell transplantation for lymphomas.
Ayala E; Tomblyn M
Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243
[TBL] [Abstract][Full Text] [Related]
8. Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.
Muhsen IN; Hashmi SK; Niederwieser D; Kroeger N; Agrawal S; Pasquini MC; Atsuta Y; Ballen KK; Seber A; Saber W; Kharfan-Dabaja MA; Rasheed W; Okamoto S; Khera N; Wood WA; Koh MBC; Greinix H; Kodera Y; Szer J; Horowitz MM; Weisdorf D; Aljurf M
Bone Marrow Transplant; 2020 Apr; 55(4):837. PubMed ID: 31616063
[TBL] [Abstract][Full Text] [Related]
9. Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Puig N; Wang L; Seshadri T; al-Farsi K; Keating A; Crump M; Kuruvilla J
Leuk Lymphoma; 2013 Mar; 54(3):507-13. PubMed ID: 22897731
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Fossilized Melts in Mantle Wedge Peridotites.
Naemura K; Hirajima T; Svojtka M; Shimizu I; Iizuka T
Sci Rep; 2020 Feb; 10(1):2789. PubMed ID: 32051519
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
Bhatt VR; Vose JM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
[TBL] [Abstract][Full Text] [Related]
12. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
[TBL] [Abstract][Full Text] [Related]
13. Publisher Correction: Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy.
Kolodziej M; Jesionek-Kupnicka D; Braun M; Atamaniuk V; Sloniec S; Cebulski J; Cholewa M; Kopczynski J; Heraud P; Tobin MJ; Vongsvivut J; Zawlik I
Sci Rep; 2020 Aug; 10(1):14137. PubMed ID: 32839501
[TBL] [Abstract][Full Text] [Related]
14. LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation.
Colita A; Colita A; Bumbea H; Croitoru A; Orban C; Lipan LE; Craciun OG; Soare D; Ghimici C; Manolache R; Gelatu I; Vladareanu AM; Pasca S; Teodorescu P; Dima D; Lupu A; Coriu D; Tomuleasa C; Tanase A
Front Oncol; 2019; 9():892. PubMed ID: 31552193
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.
Hu G; Liu Y; Li H; Zhao D; Yang L; Shen J; Hong X; Cao X; Wang Q
Cell Mol Immunol; 2020 Mar; 17(3):305-306. PubMed ID: 32071419
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with third stem cell transplant from an allogeneic donor for a patient with relapsed diffuse large B-cell lymphoma.
Takasaki H; Ishii Y; Yamamoto W; Tsuchihashi H; Motomura S; Tomita N; Ishigatsubo Y; Sakai R
Exp Clin Transplant; 2013 Apr; 11(2):199-202. PubMed ID: 23425447
[TBL] [Abstract][Full Text] [Related]
17. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma.
Villanueva ML; Vose JM
Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239
[TBL] [Abstract][Full Text] [Related]
18. Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Prutsch N; Gurnhofer E; Suske T; Liang HC; Schlederer M; Roos S; Wu LC; Simonitsch-Klupp I; Alvarez-Hernandez A; Kornauth C; Leone DA; Svinka J; Eferl R; Limberger T; Aufinger A; Shirsath N; Wolf P; Hielscher T; Sternberg C; Aberger F; Schmoellerl J; Stoiber D; Strobl B; Jäger U; Staber PB; Grebien F; Moriggl R; Müller M; Inghirami GG; Sanda T; Look AT; Turner SD; Kenner L; Merkel O
Leukemia; 2020 Nov; 34(11):3105. PubMed ID: 32665700
[TBL] [Abstract][Full Text] [Related]
19. Author Correction: Forearc carbon sink reduces long-term volatile recycling into the mantle.
Barry PH; de Moor JM; Giovannelli D; Schrenk M; Hummer DR; Lopez T; Pratt CA; Segura YA; Battaglia A; Beaudry P; Bini G; Cascante M; d'Errico G; di Carlo M; Fattorini D; Fullerton K; Gazel E; González G; Halldórsson SA; Ilanko T; Iacovino K; Kulongoski JT; Manini E; Martínez M; Miller H; Nakagawa M; Ono S; Patwardhan S; Ramírez CJ; Regoli F; Smedile F; Turner S; Vetriani C; Yücel M; Ballentine CJ; Fischer TP; Hilton DR; Lloyd KG
Nature; 2019 Nov; 575(7784):E6. PubMed ID: 31712624
[TBL] [Abstract][Full Text] [Related]
20. Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma.
Harrington CT; Sotillo E; Robert A; Hayer KE; Bogusz AM; Psathas J; Yu D; Taylor D; Dang CV; Klein PS; Hogarty MD; Geoerger B; El-Deiry WS; Wiels J; Thomas-Tikhonenko A
Leukemia; 2020 May; 34(5):1485. PubMed ID: 31758088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
